Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma.
Cristina RiobelloPaula Sánchez-FernándezVirginia N CabalRocío García-MarínLaura Suárez-FernándezBlanca VivancoVerónica Blanco-LorenzoCésar Álvarez MarcosFernando LópezJosé Luis LlorenteMario A HermsenPublished in: Cancers (2021)
Sinonasal intestinal-type adenocarcinoma (ITAC) is strongly related to occupational exposure to wood and leather dust, however, little is known on the genetic alterations involved in tumor development and progression. The aim of this study was to identify tumorigenic signaling pathways affected by gene mutations and their relation to clinical features. We applied whole exome sequencing of 120 cancer-related genes in 50 ITACs and analyzed the signaling activity of four specific pathways frequently affected by mutations. Genes involved in DNA damage response showed somatic mutations in 30% of cases, including four tumors that also harbored germline mutations. Genes in Wnt, MAPK and PI3K pathways harbored mutations in 20%, 20% and 24% of cases, respectively. Mutations and copy number gains in receptor tyrosine kinases possibly affecting MAPK and PI3K pathways occurred in 44% of cases. Expression of key pathway proteins showed no correlation to mutations in these pathways, except for nuclear β-catenin and APC/CTNNB1 mutation. No specific gene mutation, mutated pathway, nor pathway activity level showed correlation to clinical data or survival. In addition, a similar mutational profile was observed among histological subtypes. The wide spectrum of gene mutations suggests that ITAC is a genetically heterogeneous without specific characterizing gene mutations.
Keyphrases
- copy number
- signaling pathway
- dna damage response
- genome wide
- mitochondrial dna
- squamous cell carcinoma
- epithelial mesenchymal transition
- cell proliferation
- oxidative stress
- poor prognosis
- stem cells
- dna methylation
- dna repair
- young adults
- locally advanced
- climate change
- dna damage
- binding protein
- electronic health record
- risk assessment
- long non coding rna
- polycyclic aromatic hydrocarbons